---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-24-000004"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T13:52:12.883288+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# ICU Medical Q4 revenue up slightly but net loss widens; provides FY2024 guidance

## Summary
- Revenue $587.9M in Q4 2023, up 1.7% YoY from $578.0M.
- GAAP net loss $17.1M ($0.71/share) widened from $15.5M loss ($0.65/share) in Q4 2022.
- Adjusted EBITDA $86.3M vs $96.4M YoY; adjusted EPS $1.57 vs $1.60.
- Gross margin slipped to 29% from 30%; gross profit $171.6M vs $174.9M.
- Company issued FY2024 guidance (not detailed in excerpt).

## SEC filing metadata
- accession: 0000883984-24-000004
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/0000883984-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/icui-20240227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-24-000004
- JSON: https://secwatch.observer/filing/0000883984-24-000004.json
- Plain text: https://secwatch.observer/filing/0000883984-24-000004.txt

## Key facts
- Earnings Releases
  ICU MEDICAL INC/DE reported fourth quarter of 2023 results: revenue $587.9 million, net income $(17.1) million, EPS $(0.71) per diluted share.
  - Period: fourth quarter of 2023
  - Revenue: $587.9 million
  - Net income: $(17.1) million
  - EPS: $(0.71) per diluted share
  - Result: reported results
  source text: and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the same
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398424000004/0000883984-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.